Location:
Call: 040 4488 5333
[email protected]

29 July, 2026

Fertility Decline: What Women Should Know

Conversations about fertility tend to happen too late. Women often begin thinking seriously about their reproductive timeline only when they are ready to conceive. At this point, some of the most important biological facts have already been playing out for years without their awareness. The decline in female fertility with age is one of the most consistently misunderstood aspects of reproductive health, and the gap between what women know and what the biology actually shows is significant.

This is not about creating anxiety. It is about giving women accurate information early enough to make genuinely informed decisions.

The Fundamental Biology

A woman is born with all the eggs she is going to have in her lifetime. Her eggs age with her, decreasing in quality and quantity. Age is the single most important factor affecting a woman's fertility.

Females are born with a finite number of oocytes. The number of oocytes peaks in the womb at around 20 weeks of gestation and subsequently declines steadily until approximately age 32, after which the number decreases at a greater rate until age 37, beyond which oocyte numbers drop even more rapidly.

This is not something that can be slowed by fitness, diet, or general good health. Even though women today are healthier and taking better care of themselves than ever before, improved health in later life does not offset the natural age-related decline in fertility. A woman in excellent physical health at 38 still has the ovarian reserve of a 38-year-old.

When Does Fertility Actually Start Declining

This is where most women are surprised. The common understanding is that fertility drops sharply at 35. The reality is more gradual and begins earlier than most expect.

A woman's fertility begins to drop slightly around the time she reaches 30 and rapidly declines after she is in her mid-30s. Evidence indicates that fertility begins to decline after age 27 and declines substantially after age 35 compared with the 20s.

The age of 35 is clinically significant, not because fertility drops off dramatically at that time, but because significant changes in the rate of fertility decline occur at that age, and risks of pregnancy complications, such as chromosomal abnormalities in the developing embryo and miscarriage, become more noticeable. These reduced rates of birth are matched by higher rates of spontaneous abortion and aneuploidy, and older women are at higher risk of having an operative delivery, hypertensive disorders, and gestational diabetes. 

What Ovarian Reserve Means And Why It Matters

Ovarian reserve is the number and quality of eggs in the ovary at a particular point. It is the simplest indicator of a woman's fertility and can be measured by either a blood test or an ultrasound. 

As women age, especially from the mid-30s, the decline in ovarian reserve in terms of both quality and quantity happens very rapidly, and the odds for conception and successful pregnancy become progressively harder.

Anti-Mullerian hormone, commonly abbreviated as AMH, is the most widely used blood test for estimating ovarian reserve. It reflects the pool of developing follicles available in the ovaries and gives a reasonable indication of how many eggs remain. An antral follicle count on ultrasound provides complementary information. The tests provide a context for IVF and may help someone understand how likely they are to get pregnant, but they do not guarantee it or when it will occur; they are especially useful for women who are considering delaying childbearing and/or their fertility preservation options. 

Fertility Preservation: What Are the Options

Egg freezing, or medically, oocyte cryopreservation, is the most time-tested approach available for fertility preservation. It is used by women who are not ready to become pregnant but want to ensure they have the option of doing so in the future. Eggs are retrieved after a hormone stimulation cycle, then frozen for future use.

The earlier the eggs are frozen, the better the results, as their effectiveness decreases with age. Eggs frozen in the late 20s or early 30s have a much greater likelihood of producing a viable pregnancy when compared to eggs frozen in the late 30s. This is because egg quality (not quantity) declines with age, and frozen eggs reflect egg quality at the time of freezing.

Before deciding on fertility preservation, women should consult with a reproductive endocrinologist about the process and likely success rates, and the consequences of the procedure. 

Medical Conditions that Accelerate Fertility Decline

Age is not the only factor that reduces ovarian reserve. Several medical conditions can deplete egg numbers or damage ovarian tissue well ahead of the expected timeline, sometimes significantly so.

  • Endometriosis, particularly when it involves ovarian cysts called endometriomas, is one of the most common culprits. The cysts themselves can destroy functioning ovarian tissue, and the inflammatory environment that endometriosis creates further compromises the follicles surrounding them. 
  • Previous ovarian surgery carries a similar risk. Any procedure on the ovary, whether to remove a cyst, address torsion, or treat endometriosis, can inadvertently reduce the ovarian reserve if healthy follicle-containing tissue is removed alongside the targeted area. 
  • Premature ovarian insufficiency, where the ovaries stop functioning before the age of 40, can cause a dramatic and early reduction in fertility. It is associated with autoimmune conditions, certain genetic conditions such as Turner syndrome and Fragile X premutation, and in some cases, no identifiable cause at all.
  • Autoimmune conditions more broadly, including lupus, rheumatoid arthritis, and thyroid disorders, can affect ovarian function through immune-mediated damage to ovarian tissue. 
  • Cancer treatment, specifically chemotherapy and pelvic radiation, is among the most significant medical causes of accelerated ovarian reserve decline. 

An often-overlooked factor in reproductive health is daily exposure to chemicals found in cosmetics, skincare, and personal care products. These substances interfere with the body's hormonal signalling in ways that research has linked to reduced ovarian reserve and disrupted menstrual cycles. 

Choosing fragrance-free, paraben-free, and phthalate-free products where possible is a simple, practical step women can take to reduce cumulative chemical exposure as part of a broader approach to protecting their reproductive health.

Women with any of these conditions should have their ovarian reserve assessed earlier than they otherwise might, and discuss the implications for their reproductive plans with a gynaecologist or fertility specialist as soon as the diagnosis is established.

Takeaways

Fertility decline in women is a natural, gradual process related to the limited and age-related decrease in egg quality and number. Age and female fertility are directly correlated; fertility levels drop significantly after the late 20s and continue to decline after the mid-30s. Using AMH and antral follicle count can give women a great deal of information to help them evaluate their reproductive timeline. Egg freezing is best performed early in the reproductive years before a considerable loss of egg quality has taken place. Women who wish to have children, but are not ready to conceive, or those who have conditions which may help to accelerate the rate of ageing of their ovaries, should consider a reproductive consultation and not wait until it is an emergency.

SIMILAR ARTICLES

blog featured image

29 July, 2026

Irregular Periods: When to Investigate

Period irregularity is something many women experience at some point, and most learn to live with it, at least for a while. A late period during a stressful month, a lighter cycle after illness, a missed period after a long flight. These variations are common and usually self-correcting. The problem is that irregular periods are also how the body signals conditions that genuinely need attention, and because the irregularity can feel familiar, it is easy to keep waiting for things to normalise when they never will without proper evaluation.Knowing where the line sits between normal variation and something worth investigating is genuinely useful.What counts as irregularA normal menstrual cycle runs anywhere from 24 to 38 days, measured from the first day of one period to the first day of the next. Variation of up to eight days between the shortest and longest cycle is considered normal. Lengths ranging between 8 and 20 days of variation are considered moderately irregular, and variation of 21 days or more is considered very irregular.Changes outside the cycle length are also irregular. Periods that are either much heavier or lighter than normal, periods that are much longer or shorter than normal, periods between periods, and periods that are absent altogether, in a woman not pregnant, breastfeeding, or in menopause,
Read More
blog featured image

29 July, 2026

PMOS: Causes Beyond Hormones

Most patients understand Polycystic Metabolic Ovarian Syndrome, or PMOS, as a hormonal condition. Irregular periods, elevated androgens, and ovarian cysts on an ultrasound. The hormonal picture is real, but it is only part of the story. Decades of research have made it increasingly clear that PMOS is far more complex than a hormonal imbalance in isolation. It involves the metabolic system, the immune system, the gut, and genetics, all interacting in ways that produce a condition that looks different in every woman who has it.Understanding the fuller picture of what causes PMOS matters because it changes how the condition is managed and why lifestyle interventions work as well as they do.What PMOS Actually InvolvesPolycystic Metabolic Ovarian Syndrome is a complex endocrine and metabolic disorder, typically characterised by hirsutism, hyperandrogenism, ovulatory dysfunction, menstrual disorders, and infertility. The name itself reflects what the condition truly is. The metabolic component is not secondary to the ovarian and hormonal picture. It is central to it. Treating the hormonal symptoms without addressing the underlying metabolic drivers is one reason PMOS management often produces only partial results.Insulin Resistance Sits at the CentrePMOS insulin resistance, where cells throughout the body fail to respond normally to insulin, is considered the primary pathological basis for the reproductive dysfunction seen in PMOS.
Read More
blog featured image

29 July, 2026

Menopause Symptoms and Management: A Complete Guide for Women

A woman plays a pivotal role in the family today. In the era of science and technology, we see that women’s life expectancy has increased. This means that a woman passes more than one-third of her life in the menopausal age group.  Menopause is not a disease. It is a natural biological transition, the point at which a woman's menstrual cycles end permanently following the decline of ovarian function. But natural does not mean painless or uncomplicated, and for many women, the years surrounding this transition bring changes that affect sleep, mood, cognition, relationships, and physical health in ways that deserve proper attention. According to the Indian menopause society, the average age of menopause for Indian women is  46.2 years, which is 5 yrs earlier than the global average of 51 years. What does menopause actually involve?Medical professionals define menopause as having occurred when a woman has not had any menstrual bleeding for one year. The transition leading up to this point is called perimenopause, and it can begin anywhere from two to ten years before the final period. Perimenopause is when most of the symptoms that women associate with menopause actually occur, driven by the fluctuating and declining levels of oestrogen and progesterone as the ovaries wind down their function.The symptoms women
Read More
Loading booking..